Dr. Reddy's Laboratories (RDY) News Today $13.24 +0.05 (+0.34%) Closing price 03:59 PM EasternExtended Trading$13.22 -0.01 (-0.08%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share News and Trends Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest Dr. Reddy's Laboratories Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2026 September 2026 August 2026 July 2026 June 2026 May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 Time Period More filters Fewer filters Done 9,340,290 Dr. Reddy's Laboratories Ltd $RDY Shares Sold by Robeco Institutional Asset Management B.V.October 22 at 5:11 AM | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Upgraded at Wall Street ZenOctober 17, 2026 | americanbankingnews.comDr. Reddy's Laboratories (NYSE:RDY) Stock Rating Raised to "Hold" at Wall Street ZenOctober 17, 2026 | marketbeat.comDr. Reddy's Laboratories (RDY) Expected to Announce Earnings on FridayOctober 16, 2026 | americanbankingnews.comDr. Reddy's Laboratories (RDY) Expected to Announce Quarterly Earnings on FridayOctober 16, 2026 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Stock Crosses Above 200-Day Moving Average - What's Next?October 15, 2026 | americanbankingnews.comDr. Reddy's Laboratories (NYSE:RDY) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?October 15, 2026 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Zentek (OtherZTEKF) and Dr Reddy’s Laboratories (RDY)October 2, 2026 | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 24, 2026 | prnewswire.comNykredit A S Takes Position in Dr. Reddy's Laboratories Ltd $RDYSeptember 23, 2026 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 22, 2026 | globenewswire.comTakeda, Dr Reddy's to launch dengue vaccine QDENGA in India by 2027September 18, 2026 | msn.comIndia's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in IndiaSeptember 17, 2026 | reuters.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 17, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 15, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 8, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 3, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYSeptember 1, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYAugust 27, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDYAugust 25, 2026 | globenewswire.comSecurities Fraud Investigation Into Dr. Reddy's Laboratories (RDY) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzAugust 19, 2026 | tmcnet.comSecurities Fraud Investigation Into Dr. Reddy's Laboratories (RDY) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzAugust 19, 2026 | businesswire.comRDY SHAREHOLDER ALERT: Dr. Reddy's Laboratories Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsAugust 13, 2026 | businesswire.comDr. Reddy's Laboratories Ltd. Sponsored ADRAugust 12, 2026 | cnn.comDr. Reddy's Laboratories Launches Sugammadex Injection Single-Dose Vials in USAugust 5, 2026 | finance.yahoo.comDR. REDDY'S LABORATORIES INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities FraudAugust 5, 2026 | globenewswire.comDr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of ...August 4, 2026 | finance.yahoo.comDr. Reddy's Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United StatesAugust 4, 2026 | businesswire.comDr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & KorsinskyJuly 31, 2026 | prnewswire.comLevi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Dr. Reddy's Laboratories (RDY)July 29, 2026 | globenewswire.comDr Reddys Laboratories Ltd (RDY)July 28, 2026 | insidermonkey.comDr Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call Highlights: Navigating Challenges and ...July 28, 2026 | finance.yahoo.comRDY Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Dr. Reddy's Laboratories (RDY)July 28, 2026 | businesswire.comDr. Reddy's Laboratories Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Dr. Reddy's Laboratories (RDY)July 24, 2026 | prnewswire.comU.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warnsJuly 23, 2026 | cnbc.comWhy Dr. Reddy's sank: Profit plunge, semaglutide setback and Trump's tariff threatJuly 22, 2026 | msn.comDr. Reddy's Laboratories Limited (RDY) Q1 2027 Earnings Call TranscriptJuly 22, 2026 | seekingalpha.comDr. Reddy's falls after Q1 results amid Trump’s tariff threatJuly 22, 2026 | seekingalpha.comIndian drugmaker Dr Reddy's posts quarterly profit slumpJuly 22, 2026 | reuters.comDr. Reddy's Q1 earnings previewJuly 21, 2026 | msn.comDr. Reddy's Laboratories (RDY) Projected to Release Quarterly Earnings on WednesdayJuly 15, 2026 | marketbeat.comDr. Reddy's Laboratories Limited (RDY) Discusses Manufacturing Issue and Process Review for Semaglutide TranscriptJuly 10, 2026 | seekingalpha.comDr. Reddy's falls as quality issue delays supplies of Ozempic genericJuly 9, 2026 | seekingalpha.comIndia's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's noticeJuly 9, 2026 | reuters.comDr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-FJune 26, 2026 | finance.yahoo.comDr. Reddy's Laboratories Limited Announces Filing of Annual Report on Form 20-FJune 26, 2026 | businesswire.comDr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United StatesJune 13, 2026 | businesswire.comNYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoYMay 29, 2026 | prnewswire.comDr. Reddy’s Launches First Generic Semaglutide Injection in Canada After Health Canada NodMay 17, 2026 | theglobeandmail.comDr. Reddy's launches generic semaglutide in Canada, expands GLP-1 pushMay 16, 2026 | msn.com Dr. Reddy's Laboratories Media Mentions By Week Dr. Reddy's Laboratories Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼0.460.47▲Average Healthcare News Sentiment Dr. Reddy's Laboratories News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼52▲RDY Articles Average Week Dr. Reddy's Laboratories Trends on MarketBeatThis week vs. last weekNew Followers2+100%Searches1Page Views2,777+21% Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BeOne Medicines News Royalty Pharma News Zoetis News Viatris News Jazz Pharmaceuticals News Neurocrine Biosciences News Corcept Therapeutics News Elanco Animal Health News Axsome Therapeutics News Lantheus News News and Trends Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Dr. Reddy's Laboratories dated 10/22/2026. From Our PartnersFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
